Edward White

Stock Analyst at HC Wainwright & Co.

(0)
# 4257
Out of 5,267 analysts
490
Total ratings
26.57%
Success rate
-8.28%
Average return
46 Stocks
Name Action Price Target Current % Upside Ratings Updated
Valneva
Reiterates: Buy
17 17
6.89 146.73% 35 Feb 28, 2025
Puma Biotechnology
Reiterates: Buy
7 7
3.58 95.53% 20 Feb 28, 2025
Cullinan Therapeutic...
Reiterates: Buy
33 33
8.48 289.15% 23 Feb 28, 2025
Adicet Bio
Reiterates: Neutral
n/a
n/a n/a 22 Feb 27, 2025
Karyopharm Therapeut...
Maintains: Strong Buy
7 56
7.95 604.4% 28 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 10 Feb 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
31 31
13.78 124.96% 21 Feb 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
11 11
5.23 110.33% 17 Feb 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 10 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
6 6
1.7 252.94% 14 Jan 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
15 15
3.02 396.69% 6 Jan 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
8 8
1.4 471.43% 23 Jan 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
55 55
30.12 82.6% 30 Jan 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
14 16
1.2 1233.33% 12 Jan 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
4 4
0.45 788.89% 5 Jan 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
4.1 387.8% 1 Dec 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
17 17
10.05 69.15% 13 Dec 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
20 20
2.98 571.14% 17 Dec 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
51 51
15.69 225.05% 28 Dec 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
22 22
7.48 194.12% 4 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 11 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
5 5
n/a n/a 15 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Oct 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 12 Jul 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9 3
n/a n/a 13 Jun 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 12 Jun 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 9 May 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
25
n/a n/a 7 Mar 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Feb 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 4 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
101 52
n/a n/a 4 Aug 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
40 20
n/a n/a 4 Jun 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 10 May 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Apr 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Mar 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Nov 8, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
168 180
n/a n/a 7 Sep 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
28
0.5 5500% 3 Aug 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
34 30
20.5 46.34% 5 Aug 11, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
251 247
n/a n/a 14 Aug 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
17 15
n/a n/a 5 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
13 20
n/a n/a 1 Dec 10, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 26, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
12
1.12 971.43% 2 Mar 6, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
158
n/a n/a 3 Oct 12, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
10
n/a n/a 1 May 24, 2017